Supplements

Restless legs syndrome severity and neurological disability are the strongest predictors of poor sleep quality in patients with multiple sclerosis

In a cross-sectional study of 173 patients with MS, 48.0% were poor sleepers (PSQI > 5) with a mean PSQI of 6.06. XGBoost machine learning identified restless legs syndrome severity (IRLS) as the strongest predictor of PSQI, followed by EDSS (disability) and depression, while cardiometabolic and inflammatory factors contributed inconsistently.

1 min readUpdated Aug 28, 20260 RCTsView structured evidence →
Evidence Score34/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★
Confidencelow

This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.

Restless legs syndrome severity and neurological disability are the strongest predictors of poor sleep quality in patients with multiple sclerosis The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 34/100 (low).

The Claim

Restless legs syndrome severity and neurological disability are the strongest predictors of poor sleep quality in patients with multiple sclerosis

This conclusion is most relevant to: Adult patients with multiple sclerosis (mean age 39.66 years, 69.9% female, 90.2% RRMS).

What the Research Shows

The conclusion draws on 1 linked study. Highlights from the cited literature:

  • Machine Learning-Based Prediction of Sleep Quality in Patients with Multiple Sclerosis. (Medical sciences (Basel, Switzerland), 2026) —

How It Works

The proposed biological pathway:

  • Restless legs syndrome severity (IRLS) is the strongest predictor of PSQI
  • Neurological disability (EDSS) and depression also contribute significantly
  • Cardiometabolic and inflammatory factors show inconsistent and sometimes opposite effects
  • Disease-related and symptomatic factors outweigh cardiometabolic and inflammatory contributions

Who Might Benefit

Evidence fit by population:

  • Adult patients with multiple sclerosis (mean age 39.66 years, 69.9% female, 90.2% RRMS)

Limitations & Caveats

Important context when interpreting this evidence:

  • Cross-sectional design prevents causal inference
  • Modest sample size (n=173) and single-center study
  • Exploratory machine learning approach requires confirmation in larger independent cohorts

Frequently Asked Questions

What is the most important predictor of poor sleep in MS patients?

Restless legs syndrome severity (IRLS) was the strongest predictor of PSQI across all machine learning models.

How common is poor sleep in this MS cohort?

48.0% of the 173 patients were classified as poor sleepers (PSQI > 5), with a mean PSQI of 6.06.

Do cardiometabolic and inflammatory factors predict sleep quality in MS?

They contributed inconsistently and some showed effects opposite to physiological expectation, suggesting they are less important than disease-related and symptomatic factors.

What machine learning model performed best?

XGBoost achieved the best predictive performance with a test R2 of 0.451.

References

  1. 1.Cucu LE, Baciu LC, Onicescu OM, Ignat BE, Săcărescu A, Oancea A, Grosu C, Chirica C, Popescu G, Maștaleru A, Bîlcu RV, Mustață A, Roca M, Leon MM. “Machine Learning-Based Prediction of Sleep Quality in Patients with Multiple Sclerosis..” Medical sciences (Basel, Switzerland), 2026. PMID: 42646617 DOI: 10.3390/medsci14040483
Disclaimer: This article is auto-generated from structured research data for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.